209 related articles for article (PubMed ID: 8850273)
1. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.
Gann PH; Ma J; Hennekens CH; Hollis BW; Haddad JG; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):121-6. PubMed ID: 8850273
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
Ma J; Stampfer MJ; Gann PH; Hough HL; Giovannucci E; Kelsey KT; Hennekens CH; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
[TBL] [Abstract][Full Text] [Related]
3. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
4. Interaction of factors related to the metabolic syndrome and vitamin D on risk of prostate cancer.
Tuohimaa P; Tenkanen L; Syvälä H; Lumme S; Hakulinen T; Dillner J; Hakama M
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):302-7. PubMed ID: 17301263
[TBL] [Abstract][Full Text] [Related]
5. Calcium, dairy products, and the risk of prostate cancer.
Tavani A; Gallus S; Franceschi S; La Vecchia C
Prostate; 2001 Jul; 48(2):118-21. PubMed ID: 11433421
[TBL] [Abstract][Full Text] [Related]
6. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
[TBL] [Abstract][Full Text] [Related]
7. Prediagnostic plasma vascular endothelial growth factor levels and risk of prostate cancer.
Li H; Kantoff PW; Ma J; Stampfer MJ; George DJ
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1557-61. PubMed ID: 15941972
[TBL] [Abstract][Full Text] [Related]
8. Prediagnostic plasma vitamin C levels and the subsequent risk of prostate cancer.
Berndt SI; Carter HB; Landis PK; Hallfrisch J; Rohrmann S; Metter EJ; Platz EA
Nutrition; 2005 Jun; 21(6):686-90. PubMed ID: 15925292
[TBL] [Abstract][Full Text] [Related]
9. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.
Peters U; Hayes RB; Chatterjee N; Shao W; Schoen RE; Pinsky P; Hollis BW; McGlynn KA;
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):546-52. PubMed ID: 15066918
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055
[TBL] [Abstract][Full Text] [Related]
12. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
14. Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma.
Cook NR; Stampfer MJ; Ma J; Manson JE; Sacks FM; Buring JE; Hennekens CH
Cancer; 1999 Nov; 86(9):1783-92. PubMed ID: 10547552
[TBL] [Abstract][Full Text] [Related]
15. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
Stattin P; Rinaldi S; Biessy C; Stenman UH; Hallmans G; Kaaks R
J Clin Oncol; 2004 Aug; 22(15):3104-12. PubMed ID: 15284261
[TBL] [Abstract][Full Text] [Related]
16. Serum selenium and subsequent risk of prostate cancer.
Nomura AM; Lee J; Stemmermann GN; Combs GF
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):883-7. PubMed ID: 11008904
[TBL] [Abstract][Full Text] [Related]
17. Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center.
Kurahashi N; Iwasaki M; Inoue M; Sasazuki S; Tsugane S
J Clin Oncol; 2008 Dec; 26(36):5923-9. PubMed ID: 19018085
[TBL] [Abstract][Full Text] [Related]
18. Plasma selenium level before diagnosis and the risk of prostate cancer development.
Brooks JD; Metter EJ; Chan DW; Sokoll LJ; Landis P; Nelson WG; Muller D; Andres R; Carter HB
J Urol; 2001 Dec; 166(6):2034-8. PubMed ID: 11696701
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study.
McCullough ML; Stevens VL; Diver WR; Feigelson HS; Rodriguez C; Bostick RM; Thun MJ; Calle EE
Breast Cancer Res; 2007; 9(1):R9. PubMed ID: 17244366
[TBL] [Abstract][Full Text] [Related]
20. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
